Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China flag China · Delayed Price · Currency is CNY
5.59
-0.16 (-2.78%)
Aug 21, 2026, 11:29 AM CST

SHA:603168 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-273.68-238.72-123.4425.4144.7535.66
Depreciation & Amortization
70.6570.6572.6173.0265.8361.67
Other Amortization
1.71.71.341.932.271.5
Loss (Gain) From Sale of Assets
-0.9-0.9-1.050.01-15.820.21
Asset Writedown & Restructuring Costs
233.99233.9933.3413.39.48-
Loss (Gain) From Sale of Investments
-29.44-29.4416.67-16.022.51-7.21
Provision & Write-off of Bad Debts
4.984.981.17-3.094.321.72
Other Operating Activities
40.4623.9412.45.52-5.962.75
Change in Accounts Receivable
6.546.54-2.33-12.046.83-4.19
Change in Inventory
-18.62-18.625.05-25.32-0.154.11
Change in Accounts Payable
-9.96-9.969.09-7.7214.55
Change in Other Net Operating Assets
-3.41-3.410.87-12.28--
Operating Cash Flow
26.4944.9325.6741.49115.72100.78
Operating Cash Flow Growth
59.37%75.01%-38.13%-64.14%14.82%128.58%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-107.25-94.15-128.11-219.8-148.69-153.44
Sale of Property, Plant & Equipment
0.040.062.890.080.350.49
Cash Acquisitions
-6.65-6.65-6.65-51.66--
Divestitures
0.50.5----
Investment in Securities
30.2825.28-63.8-83.99103.89295.24
Other Investing Activities
0.776.7-139.999.48--
Investing Cash Flow
-82.31-68.26-335.66-345.89-44.45142.28

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-209.4185153.7348-
Long-Term Debt Repaid
--141.04-108.08-30.39-55.22-5.93
Net Debt Issued (Repaid)
37.3468.3676.92123.34-7.22-5.93
Issuance of Common Stock
---27.92314.6-
Repurchase of Common Stock
-7.69-7.69-13.67---
Common Dividends Paid
-7.94-7.94-14.53-16.25--
Other Financing Activities
-2.09--11.61-7.88-205.39
Financing Cash Flow
19.6252.7237.11135.01315.26-211.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-36.229.39-272.88-169.39386.5431.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-80.76-49.22-102.43-178.3-32.97-52.66
Free Cash Flow Growth
------
Free Cash Flow Margin
-17.57%-10.64%-21.17%-27.64%-6.00%-8.36%
Free Cash Flow Per Share
-0.23-0.13-0.27-0.49-0.10-0.16
Levered Free Cash Flow
-115.12-64.18-91.22-80.3684.68-350.93
Unlevered Free Cash Flow
-109.52-58.57-86.03-77.4785.71-350.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
29.3733.6927.7744.5149.6168.93
Change in Working Capital
-21.27-21.2712.64-58.598.354.48